Pfizer pours $25M investment into Caribou's cell therapies

Pfizer pours $25M investment into Caribou's cell therapies

Source: 
Fierce Biotech
snippet: 

Pfizer is backing Caribou Biosciences with a $25 million equity investment, money the genome editing company will pour into its allogeneic CAR-T cell therapy for multiple myeloma.